Table 3.

Monte Carlo dose calculation: accumulated dose-volume characteristics for the CTV and organs at risk. Each row indicates data from a separate patient

CTV D95 without / with electrodes	CTV EUD without / with electrodes	Accumulated min surface dose to the hottest 1 cm2 in shells up to 2, 4, 6, 8, 10 mm without electrodes	Accumulated min surface dose to the hottest 1 cm2 in shells up to 2, 4, 6, 8, 10 mm with electrodes	D2 Brain - PTV without / with electrodes
101.6 / 100.6	103.7 / 102.4	67.8 / 80.3 / 89.1 / 96.6 / 102.8	75.3 / 86.6 / 86.3 / 86.3 / 104.4	84.1 / 83.1
98.9 / 97.9	102.1 / 101.1	87.5 / 101.7 / 106.9 / 107.5 / 107.0	93.4 / 102.4 / 107.1 /107.0 /105.9	89.3 / 88.2
95.0 / 93.7	98.1 / 97.5	93.5 / 97.4 / 99.6 / 98.9 / 100.5	98.1 / 102.0 / 106.2 / 106.8 / 105.8	94.8 / 93.8
96.3 / 95.8	101.0 / 100.3	93.5 / 103.6/ 101.5 / 101.5 / 105.4	99.0 / 110.0 / 101.5 / 109.5 / 109.9	93.0 / 92.3
97.8 / 97.5	100.6 / 100.0	80.3 / 101.3 / 107.6 / 109.2 / 109.1	87.0 / 101.5 / 107.2 / 108.0 / 107.4	74.9 / 74.5
99.4 / 98.9	102.4 / 101.5	96.6 / 102.9 / 104.3 / 104.9 / 106.3	100.3 / 106.8 / 110.0 / 110.3 / 110.8	99.4 / 98.8
100.0 / 99.2	101.8 / 100.8	82.7 / 97.7 / 98.7 / 99.2 / 99.8	89.2 / 105.6 / 109.9 / 108.3 / 107.8	87.3 /86.4

Note: doses are given as relative doses normalized to the prescribed dose; four adjacent scalp+calvaria shells were defined as tissue slices of 2 mm thickness below the surface of the scalp in a depth of 0–2 mm, 2–4 mm, 4–6 mm, 6–8 mm, and 8-10 mm